Change search criteria ↓

Search results

80 projects found matching your search criteria:

  1. 1. Design and Pharmacological Evaluation of Marine Alkaloid-Inspired 5-HT2A Receptor Ligands

    Principal investigator: Szymon Kazimierz Kordylewski

    Instytut Farmakologii PAN

    Call: PRELUDIUM 24, Panel: NZ1

  2. 2. PDMS-based specially designed microfluidic channel lined with primary endothelial cells: a novel tool for experimental p…

    Principal investigator: Stefano Rocchetti

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: PRELUDIUM 20, Panel: NZ7

  3. 3. Modulation of molecular pathways by pharmacological mitochondria-targeting hydrogen sulfide donor in chronic gastric ulc…

    Principal investigator: dr Dagmara Ewa Wójcik-Grzybek

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ4

  4. 4. Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

    Principal investigator: dr Katarzyna Popiołek-Barczyk

    Instytut Farmakologii PAN

    Call: SONATA 15, Panel: NZ7

  5. 5. Endogenous carbon monoxide (CO) and novel CO-releasing prodrugs in pathophysiology and pharmacology of esophageal metapl…

    Principal investigator: prof. Marcin Magierowski

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 17, Panel: NZ4

  6. 6. Microscopic model of molecular reorientations and stability of amorphous species of pharmacologically active ingredients

    Principal investigator: prof. Jan Wojciech Wąsicki

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Fizyki

    Call: OPUS 9, Panel: ST5

  7. 7. Enzymatic preparation of new dehydrogenated pentacyclic triterpenes of pharmacological importance

    Principal investigator: dr Agnieszka Maria Wojtkiewicz

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

    Call: SONATA BIS 14, Panel: ST4

  8. 8. Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while …

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

    Call: OPUS 26, Panel: NZ5

  9. 9. "I like to move it, move it" – molecular dynamics-driven optimization of ligand residence time as an opportunity to impr…

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii PAN

    Call: OPUS 25, Panel: NZ7

  10. 10. Biological control and pharmacological regulation of RNAs implicated in aetiology of Parkinson's disease

    Principal investigator: prof. Gracjan Patryk Michlewski

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

    Call: OPUS 25, Panel: NZ1

  11. 11. Defining (sex and age) cell-specific epigenetic mechanisms underlying EnvironmentalEnrichment/Exercise as non-pharmacolo…

    Principal investigator: dr hab. Bartosz Zbigniew Wilczyński

    Uniwersytet Warszawski

    Call: JPND Call 2022, Panel: NZ2

  12. 12. Evaluation of butterbur (Petasites spp) for the antimigraine potential: Isolation of bioactive secondary metabolites (pe…

    Principal investigator: Łukasz Dawid Kulinowski

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 21, Panel: NZ7

  13. 13. Pharmacological potential of mistletoe (Viscum album L.) in the prevention of central nervous system disorders.

    Principal investigator: Anna Szurpnicka

    Narodowy Instytut Leków

    Call: PRELUDIUM 20, Panel: NZ7

  14. 14. Pharmacological protection of a kidney transplant from ischemia-reperfusion injury.

    Principal investigator: dr Anna Elżbieta Radajewska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM 20, Panel: NZ3

  15. 15. Biotechnological and pharmacological potential of bee products microbiota.

    Principal investigator: dr hab. Piotr Szweda

    Politechnika Gdańska, Wydział Chemiczny

    Call: OPUS 21, Panel: NZ9

  16. 16. Wood from pine family (Pinaceae) native to Poland as a potent source of pharmacologically active lignans

    Principal investigator: Andrzej Patyra

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: PRELUDIUM 20, Panel: NZ7

  17. 17. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha…

    Principal investigator: dr Dawid Marcin Panek

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  18. 18. Novel strategies for pharmacological modulation of platelet-derived microparticles - effects on endothelium

    Principal investigator: Agnieszka Agata Pełesz

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: PRELUDIUM 19, Panel: NZ5

  19. 19. Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system…

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

    Call: SONATINA 4, Panel: NZ7

  20. 20. In search of spectroscopic markers of autophagy based on pharmacologically induced phospholipidosis in endothelial cells

    Principal investigator: Ewelina Joanna Bik

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: PRELUDIUM 18, Panel: ST4

  21. 21. From the structure of fenestrations in live Liver Sinusoidal Endothelial Cells to real-time in vitro pharmacology

    Principal investigator: dr hab. Bartłomiej Zapotoczny

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

    Call: SONATA 15, Panel: NZ3

  22. 22. Novel pharmacological strategies for the treatment of depression

    Principal investigator: dr hab. Katarzyna Młyniec

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 16, Panel: NZ7

  23. 23. Searching for mu opioid receptor peptide agonists with G protein/beta-arrestin biased profile and their pharmacological …

    Principal investigator: dr Justyna Piekielna-Ciesielska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: SONATA 14, Panel: ST5

  24. 24. Novel multi-target ligands of aminergic GPCRs as pharmacological tools to study the pathomechanism of schzophrenia

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: OPUS 14, Panel: NZ7

  25. 25. Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 13, Panel: NZ7

  26. 26. Molecular and pharmacological approaches based on inhibition of glycolysis to overcome de novo- and antiangiogenic thera…

    Principal investigator: dr hab. Beata Teresa Pająk

    Wojskowy Instytut Higieny i Epidemiologii im. gen. Karola Kaczkowskiego

    Call: OPUS 13, Panel: NZ3

  27. 27. Towards experimental pharmacology of endothelium in vivo based on multiparameter method of the assessment of vascular en…

    Principal investigator: Anna Bar

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: PRELUDIUM 12, Panel: NZ5

  28. 28. Piperazine derivatives as active histamine H3 receptor ligands - molecular modeling, synthesis, pharmacological evaluati…

    Principal investigator: Katarzyna Anna Szczepańska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 12, Panel: NZ7

  29. 29. Evaluation of the impact of sphingosine kinase type 1 and 2 activity on the pharmacological mobilization of hematopoieti…

    Principal investigator: Mateusz Stanisław Adamiak

    Warszawski Uniwersytet Medyczny, II Wydział Lekarski z Oddziałem Nauczania w Języku Angielskim oraz Oddziałem Fizjoterapii

    Call: PRELUDIUM 12, Panel: NZ4

  30. 30. Determination of the mechanisms and potential targets for neuropathic pain therapy by investigating pharmacological inte…

    Principal investigator: Anna Piotrowska-Murzyn

    Instytut Farmakologii PAN

    Call: PRELUDIUM 12, Panel: NZ7

  31. 31. Novel multi-target directed ligands combining cholinesterase inhibition and 5-HT6 antagonism - design, synthesis and pha…

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 12, Panel: NZ7

  32. 32. Pharmacological suppression of ischemia/reperfusion injury to improve the function of the heart. Ex vivo and in vivo stu…

    Principal investigator: prof. Grzegorz Sawicki

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

    Call: OPUS 12, Panel: NZ3

  33. 33. Waxes of indigenous fruits as a source of natural compounds with a pharmacological activity.

    Principal investigator: Łukasz Grzegorz Woźniak

    Instytut Biotechnologii Przemysłu Rolno-Spożywczego im. prof. Wacława Dąbrowskiego

    Call: PRELUDIUM 11, Panel: NZ9

  34. 34. Synthesis and pharmacological characterization of structurally diverse chemical analogues of compound PO-10 as multiple …

    Principal investigator: dr hab. Agnieszka Zagórska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 11, Panel: NZ7

  35. 35. Pharmacological properties and neurotoxicity of novel NBOMe derivatives

    Principal investigator: prof. Krystyna Czesława Gołembiowska

    Instytut Farmakologii PAN

    Call: OPUS 11, Panel: NZ7

  36. 36. Design and chemical synthesis of peptide-based conjugates with antimicrobial activity - a promising approach to improve …

    Principal investigator: prof. Krzysztof Rolka

    Uniwersytet Gdański, Wydział Chemii

    Call: OPUS 11, Panel: ST5

  37. 37. Search for the functionally selective 5-HT1A receptor agonists as new pharmacological tools in the development of treatm…

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 10, Panel: NZ7

  38. 38. Co-dependence of cell-to-cell metabolite shuttles and macromolecular organization of metabolism in norm and pathology. Q…

    Principal investigator: prof. Dariusz Stanisław Rakus

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

    Call: OPUS 10, Panel: NZ1

  39. 39. NMDA receptor independent, acetylcholine induced bursting activity of midbrain dopaminergic neurons - in vivo electrophy…

    Principal investigator: Magdalena Walczak

    Uniwersytet Jagielloński, Wydział Biologii

    Call: PRELUDIUM 10, Panel: NZ4

  40. 40. Rational design and pharmacological characterization of chimeric cyclic opioid peptide analogs targeting multiple recept…

    Principal investigator: prof. Anna Ewa Janecka

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 9, Panel: ST5

  41. 41. The importance of IL-33 in the monitoring of the gastric epithelial barrier function and the regulation of inflammatory …

    Principal investigator: Adrian Łukasz Gajewski

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 9, Panel: NZ6

  42. 42. Bioanalitycal and pharmacological studies on the compensatory mechanism dependent on MNA/COX-2/PGI2 pathway in NO-defici…

    Principal investigator: Agnieszka Róża Kij

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: PRELUDIUM 9, Panel: NZ7

  43. 43. Analysis of selected physicochemical, biological and pharmacological properties of biomedical materials modified by synt…

    Principal investigator: dr Katarzyna Szałapata

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

    Call: PRELUDIUM 8, Panel: NZ7

  44. 44. Radiation-induced radical processes involving amino acids and quinoxalin-2-one derivatives relevant to their pharmacolog…

    Principal investigator: Konrad Skotnicki

    Instytut Chemii i Techniki Jądrowej

    Call: PRELUDIUM 8, Panel: ST4

  45. 45. Amine derivatives of hydantoin as selective 5-HT7 receptor ligand. Molecular modeling, synthesis and pharmacological eva…

    Principal investigator: Katarzyna Maria Kucwaj-Brysz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum Uniwersytet Jagielloński; Wydział Farmaceutyczny

    Call: PRELUDIUM 8, Panel: NZ7

  46. 46. Next generation in vitro experimental model of melanoma for pharmacological studies

    Principal investigator: prof. Małgorzata Ewa Czyż

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 8, Panel: NZ7

  47. 47. Synthesis and pharmacological evaluation of novel benzizoxazolepropylpyrolidine derivatives as multifunctional ligands w…

    Principal investigator: dr Monika Emilia Marcinkowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 8, Panel: NZ7

  48. 48. 2-Oxoglutarate dependent oxygenases in the biosynthesis of pharmacologically active alkaloids - structure, catalytic mec…

    Principal investigator: prof. Tomasz Maciej Borowski

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

    Call: SONATA BIS 4, Panel: NZ1

  49. 49. Engineering of intelligent inhalable therapeutics with the capacity for guided accumulation and triggered release of act…

    Principal investigator: prof. Elżbieta Pamuła

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Inżynierii Materiałowej i Ceramiki

    Call: HARMONIA 6, Panel: ST5

  50. 50. Role of silver nanoparticles in the process of regulation of expression of physiologically and pharmacologically importa…

    Principal investigator: Damian Ryszard Krzyżanowski

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 7, Panel: NZ3

Graphic design and implementation: Jakub Piotrowski